Skip to main content
SpringerLink
Log in

Vascular management during transcatheter aortic valve replacement

  • Invited Review Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Transcatheter aortic valve replacement (TAVR), as an alternative to open heart surgery, has been established as the standard therapy for patients with severe aortic valve stenosis. Vascular access management, the first step in a TAVR procedure, should be managed properly. Moreover, the transfemoral and alternatives such as the transaxillary/subclavian, transcarotid, transapical, and transcaval approaches are considered access routes during TAVR. More than 90% of cases can be treated via the transfemoral approach in the current TAVR era, whereas other approaches should be considered in patients in whom the transfemoral approach is not suitable. Vascular complications regardless of access route differences are a specific issue of TAVR caused by the use of large sheaths. With the increased number of TAVR cases, we must manage vascular complications and decrease the morbidity and mortality rates associated with TAVR procedures. Thus, this study aimed to review the vascular complications during TAVR and summarize their prognosis, prevention, and adequate management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article.

References

  1. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–705.

    Article  Google Scholar 

  2. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706–15.

    Article  Google Scholar 

  3. Walther T, Hamm CW, Schuler G, Berkowitsch A, Kotting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015;65:2173–80.

    Article  Google Scholar 

  4. van Wiechen MP, Tchétché D, Ooms JF, Hokken TW, Kroon H, Ziviello F, Ghattas A, Siddiqui S, Laperche C, Spitzer E, et al. Suture- or plug-based large-bore arteriotomy closure: a pilot randomized controlled trial. JACC Cardiovasc Interv. 2021;14:149–57.

    Article  Google Scholar 

  5. Akodad M, Roubille F, Marin G, Lattuca B, Macia JC, Delseny D, Gandet T, Robert P, Schmutz L, Piot C, et al. Myocardial injury after balloon predilatation versus direct transcatheter aortic valve replacement: insights from the DIRECTAVI trial. J Am Heart Assoc. 2020;9: e018405.

    Article  CAS  Google Scholar 

  6. Yong G, Walton T, Ng M, Gurvitch R, Worthley S, Whitbourn R, Jepson N, Bhindi R, Shang K, Sinhal A. Performance and safety of transfemoral TAVI with SAPIEN XT in Australian patients with severe aortic stenosis at intermediate surgical risk: SOLACE-AU trial. Heart Lung Circ. 2020;29:1839–46.

    Article  Google Scholar 

  7. Makkar RR, Cheng W, Waksman R, Satler LF, Chakravarty T, Groh M, Abernethy W, Russo MJ, Heimansohn D, Hermiller J, et al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet. 2020;396:669–83.

    Article  Google Scholar 

  8. Waksman R, Craig PE, Torguson R, Asch FM, Weissman G, Ruiz D, Gordon P, Ehsan A, Parikh P, Bilfinger T, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2020;13:1019–27.

    Article  Google Scholar 

  9. Lanz J, Kim WK, Walther T, Burgdorf C, Möllmann H, Linke A, Redwood S, Thilo C, Hilker M, Joner M, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019;394:1619–28.

    Article  Google Scholar 

  10. Khan JM, Greenbaum AB, Babaliaros VC, Rogers T, Eng MH, Paone G, Leshnower BG, Reisman M, Satler L, Waksman R, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv. 2019;12:1240–52.

    Article  Google Scholar 

  11. Toutouzas K, Benetos G, Voudris V, Drakopoulou M, Stathogiannis K, Latsios G, Synetos A, Antonopoulos A, Kosmas E, Iakovou I, et al. Pre-dilatation versus no pre-dilatation for implantation of a self-expanding valve in all comers undergoing TAVR: the DIRECT trial. JACC Cardiovasc Interv. 2019;12:767–77.

    Article  Google Scholar 

  12. Barbanti M, van Mourik MS, Spence MS, Iacovelli F, Martinelli GL, Muir DF, Saia F, Bortone AS, Densem CG, van der Kley F, et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial. EuroIntervention. 2019;15:147–54.

    Article  Google Scholar 

  13. Beve M, Auffret V, Belhaj Soulami R, Tomasi J, Anselmi A, Roisne A, Boulmier D, Bedossa M, Leurent G, Donal E, et al. Comparison of the transarterial and transthoracic approaches in nontransfemoral transcatheter aortic valve implantation. Am J Cardiol. 2019;123:1501–9.

    Article  Google Scholar 

  14. Feldman TE, Reardon MJ, Rajagopal V, Makkar RR, Bajwa TK, Kleiman NS, Linke A, Kereiakes DJ, Waksman R, Thourani VH, et al. Effect of mechanically expanded vs self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high-risk patients with aortic stenosis: the REPRISE III randomized clinical trial. JAMA. 2018;319:27–37.

    Article  Google Scholar 

  15. Yamawaki M, Araki M, Ito T, Honda Y, Tokuda T, Ito Y, Ueno H, Mizutani K, Tabata M, Higashimori A, et al. Ankle-brachial pressure index as a predictor of the 2-year outcome after transcatheter aortic valve replacement: data from the Japanese OCEAN-TAVI registry. Heart Vessel. 2018;33:640–50.

    Article  Google Scholar 

  16. Denegri A, Nietlispach F, Kottwitz J, Suetsch G, Haager P, Rodriguez H, Taramasso M, Obeid S, Maisano F. Real-world procedural and 30-day outcome using the Portico transcatheter aortic valve prosthesis: a large single center cohort. Int J Cardiol. 2018;253:40–4.

    Article  Google Scholar 

  17. Seeger J, Gonska B, Rottbauer W, Wöhrle J. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome. Cardiovasc Interv Ther. 2018;33:247–55.

    Article  Google Scholar 

  18. Hengstenberg C, Chandrasekhar J, Sartori S, Lefevre T, Mikhail G, Meneveau N, Tron C, Jeger R, Kupatt C, Vogel B, et al. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: results from the BRAVO 3 randomized trial. Catheter Cardiovasc Interv. 2017;90:1027–37.

    Article  Google Scholar 

  19. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31.

    Article  Google Scholar 

  20. Popma JJ, Reardon MJ, Khabbaz K, Harrison JK, Hughes GC, Kodali S, George I, Deeb GM, Chetcuti S, Kipperman R, et al. Early clinical outcomes after transcatheter aortic valve replacement using a novel self-expanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery: results of the evolut R US study. JACC Cardiovasc Interv. 2017;10:268–75.

    Article  Google Scholar 

  21. Takimoto S, Saito N, Minakata K, Shirai S, Isotani A, Arai Y, Hanyu M, Komiya T, Shimamoto T, Goto T, et al. Favorable clinical outcomes of transcatheter aortic valve implantation in Japanese patients—first report from the post-approval K-TAVI registry. Circ J. 2016;81:103–9.

    Article  Google Scholar 

  22. Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, et al. Neurologic complications of unprotected transcatheter aortic valve implantation (from the neuro-TAVI trial). Am J Cardiol. 2016;118:1519–26.

    Article  Google Scholar 

  23. Seeger J, Gonska B, Rodewald C, Rottbauer W, Wöhrle J. Impact of suture mediated femoral access site closure with the prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation. Int J Cardiol. 2016;223:564–7.

    Article  Google Scholar 

  24. Manoharan G, Linke A, Moellmann H, Redwood S, Frerker C, Kovac J, Walther T. Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the portico system. EuroIntervention. 2016;12:768–74.

    Article  Google Scholar 

  25. Wöhrle J, Gonska B, Rodewald C, Seeger J, Scharnbeck D, Rottbauer W. Transfemoral aortic valve implantation with the repositionable lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience. EuroIntervention. 2016;12:760–7.

    Article  Google Scholar 

  26. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.

    Article  CAS  Google Scholar 

  27. Wöhrle J, Gonska B, Rodewald C, Seeger J, Scharnbeck D, Rottbauer W. Transfemoral aortic valve implantation with the new Edwards sapien 3 valve for treatment of severe aortic stenosis-impact of valve size in a single center experience. PLoS ONE. 2016;11: e0151247.

    Article  Google Scholar 

  28. Webb JG, Doshi D, Mack MJ, Makkar R, Smith CR, Pichard AD, Kodali S, Kapadia S, Miller DC, Babaliaros V, et al. A randomized evaluation of the SAPIEN XT transcatheter heart valve system in patients with aortic stenosis who are not candidates for surgery. JACC Cardiovasc Interv. 2015;8:1797–806.

    Article  Google Scholar 

  29. Binder RK, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Pedrazzini G, Amann FW, Ferrari E, Noble S, et al. Procedural results and clinical outcomes of transcatheter aortic valve implantation in Switzerland: an observational cohort study of sapien 3 versus sapien XT transcatheter heart valves. Circ Cardiovasc Interv. 2015;8: e002653.

    Article  Google Scholar 

  30. Manoharan G, Walton AS, Brecker SJ, Pasupati S, Blackman DJ, Qiao H, Meredith IT. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8:1359–67.

    Article  Google Scholar 

  31. Abramowitz Y, Chakravarty T, Jilaihawi H, Kashif M, Zadikany R, Lee C, Matar G, Cheng W, Makkar RR. Comparison of outcomes of transcatheter aortic valve implantation in patients ≥ 90 years versus. Am J Cardiol. 2015;116:1110–5.

    Article  Google Scholar 

  32. Bosmans J, Bleiziffer S, Gerckens U, Wenaweser P, Brecker S, Tamburino C, Linke A. The incidence and predictors of early and mid-term clinically relevant neurological events after transcatheter aortic valve replacement in real-world patients. J Am Coll Cardiol. 2015;66:209–17.

    Article  Google Scholar 

  33. Wendt D, Al-Rashid F, Kahlert P, Eißmann M, El-Chilali K, Jánosi RA, Pasa S, Tsagakis K, Liakopoulos O, Erbel R, et al. Low incidence of paravalvular leakage with the balloon-expandable sapien 3 transcatheter heart valve. Ann Thorac Surg. 2015;100:819–25 (discussion 825–816).

    Article  Google Scholar 

  34. Castellant P, Didier R, Bezon E, Couturaud F, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, et al. Comparison of outcome of transcatheter aortic valve implantation with versus without previous coronary artery bypass grafting (from the FRANCE 2 registry). Am J Cardiol. 2015;116:420–5.

    Article  Google Scholar 

  35. Baumbach A, Mullen M, Brickman AM, Aggarwal SK, Pietras CG, Forrest JK, Hildick-Smith D, Meller SM, Gambone L, den Heijer P, et al. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. EuroIntervention. 2015;11:75–84.

    Article  Google Scholar 

  36. Fearon WF, Kodali S, Doshi D, Fischbein MP, Yeung AC, Tuzcu EM, Rihal CS, Babaliaros V, Zajarias A, Herrmann HC, et al. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (placement of AoRTic TraNscathetER valves) trial with the NRCA (nonrandomized continued access) registry. JACC Cardiovasc Interv. 2014;7:1245–51.

    Article  Google Scholar 

  37. Reardon MJ, Adams DH, Coselli JS, Deeb GM, Kleiman NS, Chetcuti S, Yakubov SJ, Heimansohn D Jr., Hermiller J, Hughes GC, et al. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. J Thorac Cardiovasc Surg. 2014;148:2869–76.

    Article  Google Scholar 

  38. Watanabe Y, Hayashida K, Takayama M, Mitsudo K, Nanto S, Takanashi S, Komiya T, Kuratani T, Tobaru T, Goto T, et al. First direct comparison of clinical outcomes between European and Asian cohorts in transcatheter aortic valve implantation: The Massy study group vs. the PREVAIL JAPAN trial. J Cardiol. 2015;65:112–6.

    Article  Google Scholar 

  39. Stabile E, Pucciarelli A, Cota L, Sorropago G, Tesorio T, Salemme L, Popusoi G, Ambrosini V, Cioppa A, Agrusta M, et al. SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol. 2014;174:624–7.

    Article  Google Scholar 

  40. Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.

    Article  Google Scholar 

  41. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M Jr., Hermiller J, Kleiman NS, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.

    Article  CAS  Google Scholar 

  42. Sawa Y, Saito S, Kobayashi J, Niinami H, Kuratani T, Maeda K, Kanzaki H, Komiyanaka Y, Boyle A, et al. First clinical trial of a self-expandable transcatheter heart valve in Japan in patients with symptomatic severe aortic stenosis. Circ J. 2014;78:1083–90.

    Article  Google Scholar 

  43. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D Jr., Hermiller J, Hughes GC, Harrison JK, Coselli J, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–81.

    Article  Google Scholar 

  44. Seco M, Martinez G, Bannon PG, Cartwright BL, Adams M, Ng M, Wilson MK, Vallely MP. Transapical aortic valve implantation—an Australian experience. Heart Lung Circ. 2014;23:462–8.

    Article  Google Scholar 

  45. Czerwi ´nska-Jelonkiewicz, K.; Michałowska, I.; Witkowski, A.; D ˛abrowski, M.; Ksi ‘ezycka-Majczy’ nska, E.; Chmielak, Z.; Ku´smier- ˙ ski, K.; Hryniewiecki, T.; Demkow, M.; St ˛epi ´nska, J. Vascular complications after transcatheter aortic valve implantation (TAVI): Risk and long-term results. J. Thromb. Thrombolysis 2014, 37, 490–498. J. Clin. Med. 2021, 10, 5046 17 of 21

  46. Holper EM, Kim RJ, Mack M, Brown D, Brinkman W, Herbert M, Stewart W, Vance K, Bowers B, Dewey T. Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR. Catheter Cardiovasc Interv. 2014;83:457–64.

    Article  Google Scholar 

  47. Généreux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, Davidson CJ, Eisenhauer AC, Makkar RR, Bergman GW, et al. Vascular complications after transcatheter aortic valve replacement: Insights from the PARTNER (placement of AoRTic TraNscathetER valve) trial. J Am Coll Cardiol. 2012;60:1043–52.

    Article  Google Scholar 

  48. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  Google Scholar 

  49. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  Google Scholar 

  50. Bleiziffer S, Ruge H, Mazzitelli D, Schreiber C, Hutter A, Krane M, Bauernschmitt R, Lange R. Valve implantation on the beating heart: Catheter-assisted surgery for aortic stenosis. Dtsch Arztebl Int. 2009;106:235–41.

    Google Scholar 

  51. Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4:851–8.

    Article  Google Scholar 

  52. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. Eur Heart J. 2011;32:205–17.

    Article  Google Scholar 

  53. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. Eur Heart J. 2012;33:2403–18.

    Article  Google Scholar 

  54. Genereux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–26.

    Article  Google Scholar 

  55. Ruge H, Burri M, Erlebach M, Lange R. Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR. Catheter Cardiovasc Interv. 2022. https://doi.org/10.1002/ccd.30088.

    Article  Google Scholar 

  56. Phan DQ, Qattan M, Lee MS, Zadegan R, Mansukhani P, Brar SS, Aharonian V, Moore N. Comparison of a single versus double perclose technique for percutaneous transfemoral transcatheter aortic valve replacement. J Invasive Cardiol. 2021;33(7):E540–8.

    Google Scholar 

  57. Beurtheret S, Karam N, Resseguier N, Houel R, Modine T, Folliguet T, Chamandi C, Com O, Gelisse R, Bille J, et al. Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement. J Am Coll Cardiol. 2019;74:2728–39.

    Article  CAS  Google Scholar 

  58. Abdelaziz HK, Megaly M, Debski M, Rahbi H, Kamal D, Saad M, Wiper A, More R, Roberts DH. Meta-analysis comparing percutaneous to surgical access in trans-femoral transcatheter aortic valve implantation. Am J Cardiol. 2020;125:1239–48.

    Article  Google Scholar 

  59. Reidy C, Sophocles A, Ramakrishna H, Ghadimi K, Patel PA, Augoustides JG. Challenges after the first decade of transcatheter aortic valve replacement: focus on vascular complications, stroke, and paravalvular leak. J Cardiothorac Vasc Anesth. 2013;27:184–9.

    Article  Google Scholar 

  60. Toggweiler S, Gurvitch R, Leipsic J, Wood DA, Willson AB, Binder RK, Cheung A, Ye J, Webb JG. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113–8.

    Article  Google Scholar 

  61. Steinvil A, Leshem-Rubinow E, Halkin A, Abramowitz Y, Ben-Assa E, Shacham Y, Bar-Dayan A, Keren G, Banai S, Finkelstein A. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions. Am J Cardiol. 2015;115:100–6.

    Article  Google Scholar 

  62. Piccolo R, Pilgrim T, Franzone A, Valgimigli M, Haynes A, Asami M, Lanz J, Räber L, Praz F, Langhammer B, Roost E, Windecker S, Stortecky S. Frequency, timing, and impact of access-site and non-access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10(14):1436–46.

    Article  Google Scholar 

  63. Honda Y, Yamawaki M, Nakano T, Makino K, Ito Y, Yashima F, Tada N, Naganuma T, Yamanaka F, Mizutani K, Tabata M, Ueno H, Takagi K, Watanabe Y, Yamamoto M, Shirai S, Hayashida K. Successfully managed access-site complication was not associated with worse outcome after percutaneous transfemoral transcatheter aortic valve implantation: up-to-date insights from the OCEAN-TAVI registry. Cardiovasc Revasc Med. 2021;S1553–8389(21):00570–4.

    Google Scholar 

  64. Humphries KH, Toggweiler S, Rodes-Cabau J, Nombela-Franco L, Dumont E, Wood DA, Willson AB, Binder RK, Freeman M, Lee MK, et al. Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2012;60:882–6.

    Article  Google Scholar 

  65. Kadakia MB, Herrmann HC, Desai ND, Fox Z, Ogbara J, Anwaruddin S, Jagasia D, Bavaria JE, Szeto WY, Vallabhajosyula P, et al. Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approaches. Circ Cardiovasc Interv. 2014;7:570–6.

    Article  Google Scholar 

  66. Lange R, Bleiziffer S, Piazza N, Mazzitelli D, Hutter A, Tassani-Prell P, Laborde JC, Bauernschmitt R. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg. 2011;40:1105–13.

    Google Scholar 

  67. Sardar MR, Goldsweig AM, Abbott JD, Sharaf BL, Gordon PC, Ehsan A, Aronow HD. Vascular complications associated with transcatheter aortic valve replacement. Vasc Med. 2017;22:234–44.

    Article  Google Scholar 

  68. Mach M, Poschner T, Hasan W, Szalkiewicz P, Andreas M, Winkler B, Geisler S, Geisler D, Rudzinski PN, Watzal V, et al. Iliofemoral tortuosity score predicts access and bleeding complications during transfemoral transcatheter aortic valve replacement. Eur J Clin Investig. 2021;51:e13491.

    Article  Google Scholar 

  69. Kim D, Orron DE, Skillman JJ, Kent KC, Porter DH, Schlam BW, Carrozza J, Reis GJ, Baim DS. Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Catheter Cardiovasc Diagn. 1992;25:91–7.

    Article  CAS  Google Scholar 

  70. Ellis SG, Bhatt D, Kapadia S, Lee D, Yen M, Whitlow PL. Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;67:541–5.

    Article  Google Scholar 

  71. Yoo BS, Yoon J, Ko JY, Kim JY, Lee SH, Hwang SO, Choe KH. Anatomical consideration of the radial artery for transradial coronary procedures: arterial diameter, branching anomaly and vessel tortuosity. Int J Cardiol. 2005;101:421–7.

    Article  Google Scholar 

  72. Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT, Suh WM, Vera JA, Aston CE, Winters RJ, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (femoral arterial access with ultrasound trial). JACC Cardiovasc Interv. 2010;3:751–8.

    Article  Google Scholar 

  73. Turi ZG. Fluoroscopy guided vascular access: asking the right question, but getting the wrong answer? Catheter Cardiovasc Interv. 2009;74:540–2.

    Article  Google Scholar 

  74. Schnyder G, Sawhney N, Whisenant B, Tsimikas S, Turi ZG. Common femoral artery anatomy is influenced by demographics and comorbidity: Implications for cardiac and peripheral invasive studies. Catheter Cardiovasc Interv. 2001;53:289–95.

    Article  CAS  Google Scholar 

  75. Bruschi G, de Marco F, Botta L, Cannata A, Oreglia J, Colombo P, Barosi A, Colombo T, Nonini S, Paino R, et al. Direct aortic access for transcatheter self-expanding aortic bioprosthetic valves implantation. Ann Thorac Surg. 2012;94:497–503.

    Article  Google Scholar 

  76. Hernández-Enriquez M, Andrea R, Brugaletta S, Jiménez-Quevedo P, Hernández-García JM, Trillo R, Larman M, Fernández-Avilés F, Vázquez-González N, Iñiguez A, et al. Puncture versus surgical cutdown complications of transfemoral aortic valve implantation (from the Spanish TAVI registry). Am J Cardiol. 2016;118:578–84.

    Article  Google Scholar 

  77. Mach M, Wilbring M, Winkler B, Alexiou K, Kappert U, Delle-Karth G, Grabenwöger M, Matschke K. Cut-down outperforms complete percutaneous transcatheter valve implantation. Asian Cardiovasc Thorac Ann. 2018;26:107–13.

    Article  Google Scholar 

  78. Nakamura M, Chakravarty T, Jilaihawi H, Doctor N, Dohad S, Fontana G, Cheng W, Makkar RR. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure. Catheter Cardiovasc Interv. 2014;84:293–300.

    Article  Google Scholar 

  79. Kawashima H, Watanabe Y, Kozuma K, Nara Y, Hioki H, Kataoka A, Yamamoto M, Takagi K, Araki M, Tada N, et al. Propensity-matched comparison of percutaneous and surgical cut-down approaches in transfemoral transcatheter aortic valve implantation using a balloon-expandable valve. EuroIntervention. 2017;12:1954–61.

    Article  Google Scholar 

  80. Mylotte D, Sudre A, Teiger E, Obadia JF, Lee M, Spence M, Khamis H, Al Nooryani A, Delhaye C, Amr G, et al. Transcarotid transcatheter aortic valve replacement: feasibility and safety. JACC Cardiovasc Interv. 2016;9:472–80.

    Article  Google Scholar 

  81. Debry N, Delhaye C, Azmoun A, Ramadan R, Fradi S, Brenot P, Sudre A, Moussa MD, Tchetche D, Ghostine S, et al. Transcarotid transcatheter aortic valve replacement: general or local anesthesia. JACC Cardiovasc Interv. 2016;9:2113–20.

    Article  Google Scholar 

  82. Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly “no-access option” patients. Catheter Cardiovasc Interv. 2010;75:1129–36.

    Google Scholar 

  83. Bapat V, Khawaja MZ, Attia R, Narayana A, Wilson K, Macgillivray K, Young C, Hancock J, Redwood S, Thomas M. Transaortic transcatheter aortic valve implantation using Edwards sapien valve: a novel approach. Catheter Cardiovasc Interv. 2012;79:733–40.

    Article  Google Scholar 

  84. Hayashida K, Romano M, Lefevre T, Chevalier B, Farge A, Hovasse T, Le Houerou D, Morice MC. The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience. Eur J Cardiothorac Surg. 2013;44:692–700.

    Article  Google Scholar 

  85. Lardizabal JA, O’Neill BP, Desai HV, Macon CJ, Rodriguez AP, Martinez CA, Alfonso CE, Bilsker MS, Carillo RG, Cohen MG, et al. The transaortic approach for transcatheter aortic valve replacement: Initial clinical experience in the United States. J Am Coll Cardiol. 2013;61:2341–5.

    Article  Google Scholar 

  86. Thourani VH, Gunter RL, Neravetla S, Block P, Guyton RA, Kilgo P, Lerakis S, Devireddy C, Leshnower B, Mavromatis K, et al. Use of transaortic, transapical, and transcarotid transcatheter aortic valve replacement in inoperable patients. Ann Thorac Surg. 2013;96:1349–57.

    Article  Google Scholar 

  87. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, et al. Transcatheter aortic valve implantation: Impact on clinical and valve-related outcomes. Circulation. 2009;119:3009–16.

    Article  Google Scholar 

  88. Walther T, Thielmann M, Kempfert J, Schroefel H, Wimmer-Greinecker G, Treede H, Wahlers T, Wendler O. PREVAIL TRANSAPICAL: Multicentre trial of transcatheter aortic valve implantation using the newly designed bioprosthesis (SAPIEN-XT) and delivery system (ASCENDRA-II). EurJ Cardiothorac Surg. 2012;42:278–83.

    Article  Google Scholar 

  89. Holzhey DM, Hansig M, Walther T, Seeburger J, Misfeld M, Linke A, Borger MA, Mohr FW. Transapical aortic valve implantation—the Leipzig experience. Ann Cardiothorac Surg. 2012;1:129–37.

    Google Scholar 

  90. Toppen W, Suh W, Aksoy O, Benharash P, Bowles C, Shemin RJ, Kwon M. Vascular complications in the Sapien 3 era: continued role of transapical approach to transcatheter aortic valve replacement. Semin Thorac Cardiovasc Surg. 2018;30:144–9.

    Article  Google Scholar 

  91. Foerst J. Percutaneous repair of left ventricular wire perforation complicating transcatheter aortic valve replacement for aortic regurgitation. JACC Cardiovasc Interv. 2016;9(13):1410–1.

    Article  Google Scholar 

  92. Sasaki K, Watanabe Y, Kataoka A, Kozuma K. Papillary muscle rupture during transcatheter aortic valve replacement. Cardiovasc Interv Ther. 2021;36(1):134–5. https://doi.org/10.1007/s12928-020-00654-6 (Epub 2020 Mar 6).

    Article  Google Scholar 

  93. Nielsen NE, Baranowska J, Bramlage P, Baranowski J. Minimizing the risk for left ventricular rupture during transcatheter aortic valve implantation by reducing the presence of stiff guidewires in the ventricle. Interact Cardiovasc Thorac Surg. 2019;29(3):365–70. https://doi.org/10.1093/icvts/ivz107 (PMID: 31135035).

    Article  Google Scholar 

  94. Brodmann M, Werner M, Brinton TJ, Illindala U, Lansky A, Lansky MR, Lansky A. Safety and performance of lithoplasty for treatment of calcified peripheral artery lesions. J Am Coll Cardiol. 2017;70:908–10.

    Article  Google Scholar 

  95. Brodmann M, Werner M, Holden A, Tepe G, Scheinert D, Schwindt A, Wolf F, Jaff M, Lansky A, Zeller T. Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II. Catheter Cardiovasc Interv. 2019;93:335–42.

    Article  Google Scholar 

  96. Di Mario C, Chiriatti N, Stolcova M, Meucci F, Squillantini G. Lithoplasty- assisted transfemoral aortic valve implantation. Eur Heart J; 2018 Feb 14.https://doi.org/10.1093/eurheartj/ehy074.

  97. Di Mario C, Goodwin M, Ristalli F, Ravani M, Meucci F, Stolcova M, Sardella G, Salvi N, Bedogni F, Berti S, et al. A prospective registry of intravascular lithotripsy-enabled vascular access for transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12:502–4.

    Article  Google Scholar 

  98. Barbanti M, Binder RK, Freeman M, Wood DA, Leipsic J, Cheung A, Ye J, Tan J, Toggweiler S, Yang TH, et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention. 2013;9:929–35.

    Article  Google Scholar 

  99. Ruge H, Burri M, Erlebach M, Lange R. Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR. Catheter Cardiovasc Interv. 2022;99(5):1611–8.

    Article  Google Scholar 

  100. Tchetche D, Dumonteil N, Sauguet A, Descoutures F, Luz A, Garcia O, Soula P, Gabiache Y, Fournial G, Marcheix B, et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention. 2010;5:659–65.

    Article  Google Scholar 

  101. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62–9.

    Article  Google Scholar 

  102. Spitzer SG, Wilbring M, Alexiou K, Stumpf J, Kappert U, Matschke K. Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI? Catheter Cardiovasc Interv. 2016;88:E52–8.

    Article  Google Scholar 

  103. Sharp AS, Michev I, Maisano F, Taramasso M, Godino C, Latib A, Denti P, Dorigo E, Giacomini A, Iaci G, et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010;75:784–93.

    Article  Google Scholar 

  104. Kahlert P, Al-Rashid F, Plicht B, Konorza T, Neumann T, Thielmann M, Wendt D, Erbel R, Eggebrecht H. Suturemediated arterial access site closure after transfemoral aortic valve implantation. Catheter Cardiovasc Interv. 2013;81:E139–50.

    Article  Google Scholar 

  105. Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: Impact of learning curve on vascular complications. JACC Cardiovasc Interv. 2012;5:207–14.

    Article  Google Scholar 

  106. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.

    Article  Google Scholar 

  107. Kodama A, Yamamoto M, Shimura T, Kagase A, Koyama Y, Tada N, Takagi K, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) Japanese multicenter registry. Catheter Cardiovasc Interv. 2017;90(3):E55–62.

    Article  Google Scholar 

  108. Koyama Y, Yamamoto M, Kagase A, Tsujimoto S, Kano S, Shimura T, Hosoba S, Watanabe Y, Tada N, Naganuma T, Araki M, Yamanaka F, Mizutani K, Tabata M, Ueno H, Takagi K, Higashimori A, Shirai S, Hayashida K. Prognostic impact and periprocedural complications of chronic steroid therapy in patients following transcatheter aortic valve replacement: Propensity-matched analysis from the Japanese OCEAN registry. Catheter Cardiovasc Interv. 2020;95(4):793–802.

    Article  Google Scholar 

  109. Bonser RS, Ranasinghe AM, Loubani M, Evans JD, Thalji NMA, Bachet JE, Thierry PC, Czerny M, Bartolomeo RD, Grabenwöger M, Lonn L, Mestres CA, Schepens MAAM, Weigang E. Evidence, lack of evidence, controversy, and debate in the provision and performance of the surgery of acute type a aortic dissection. J Am Coll Cardiol. 2011;58(24):2455–74.

    Article  Google Scholar 

  110. Yamaguchi R, Yamamoto M, Shimura T, Adachi Y, Sago M. Rescue percutaneous stenting for cerebral malperfusion with acute aortic dissection Following TAVR. JACC Case Rep. 2021;3(15):1700–4.

    Article  Google Scholar 

  111. Nagasawa A, Shirai S, Hanyu M, Arai Y, Kamioka N, Hayashi M. Descending aortic dissection injured by tip of the sheath during transcatheter aortic valve implantation. Cardiovasc Interv Ther. 2016;31:122–7.

    Article  Google Scholar 

  112. Kakefuda Y, Hayashida K, Yamada Y, Yashima F, Inohara T, Yanagisawa R, Tanaka M, Arai T, Kawakami T, Maekawa Y, Tsuruta H, Itabashi Y, Murata M, Sano M, Okamoto K, Yoshitake A, Shimizu H, Jinzaki M, Fukuda K. Impact of subclinical vascular complications detected by systematic postprocedural multidetector computed tomography after transcatheter aortic valve implantation using balloon-expandable edwards SAPIEN XT heart valve. Am J Cardiol. 2017;119(7):1100–5.

    Article  Google Scholar 

  113. Hansson NC, Nørgaard BL, Barbanti M, Nielssen NNE, Yang TH, Tamburino C, Dvir D, Jilaihawi H, Blanke P, Makkar RR, et al. The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2015;9:382–92.

    Article  Google Scholar 

  114. Barbanti M, Yang TH, Rodès CJ, Tamburino C, Wood DA, Jilaihawi H, Blanke P, Makkar RR, Latib A, Colombo A, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128:244–53.

    Article  Google Scholar 

  115. Hiltrop N, Adriaenssens T, Dymarkowski S, Herijgers P, Dubois C. Aortic annulus rupture during TAVI: a therapeutic dilemma in the inoperable patient. J Heart Valve Dis. 2015;24:436–8.

    Google Scholar 

  116. Hayashida K, Bouvier E, Lefevre T, Hovasse T, Morice MC, Chevalier B, Romano M, Garot P, Farge A, Donzeau-Gouge P, et al. Potential mechanism of annulus rupture during transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013;82:E742–6.

    Article  Google Scholar 

  117. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench aortic national corevalve and Edwards) registry. Eur Heart J. 2011;32:191–7.

    Article  Google Scholar 

  118. Tsetis D. Endovascular treatment of complications of femoral arterial access. Cardiovasc Interv Radiol. 2010;33:457–68.

    Article  Google Scholar 

  119. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, Tuzcu ME, Kodali S, Leon MB, Webb JG. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv. 2009;2:811–20.

    Article  Google Scholar 

  120. Masson JB, Al Bugami S, Webb JG. Endovascular balloon occlusion for catheter-induced large artery perforation in the catheterization laboratory. Catheter Cardiovasc Interv. 2009;73:514–8.

    Article  Google Scholar 

  121. Sago M, Shimura T, Yamaguchi R, Adachi Y, Tsunaki T, Yamamoto M. Delayed re-bleeding after balloon-expandable stent-graft implantation for an iliac artery rupture during transcatheter aortic valve implantation. Cardiovasc Interv Ther. 2022;37(1):228–9.

    Article  Google Scholar 

  122. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW. Vascular complications with transcatheter aortic valve implantation using the 18 Fr medtronic corevalve system: the rotterdam experience. EuroIntervention. 2010;5:673–9.

    Article  Google Scholar 

  123. Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, Slater J. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the national heart, lung, and blood institute dynamic registry. Catheter Cardiovasc Interv. 2007;69:961–6.

    Article  Google Scholar 

  124. Tonnessen BH. Iatrogenic injury from vascular access and endovascular procedures. Perspect Vasc Surg Endovasc Ther. 2011;23:128–35.

    Article  Google Scholar 

  125. Stone PA, Campbell JE, AbuRahma AF. Femoral pseudoaneurysms after percutaneous access. J Vasc Surg. 2014;4(60):1359–66 (J. Clin. Med. 2021, 10, 5046 21 of 21).

    Article  Google Scholar 

  126. Kresowik TF, Khoury MD, Miller BV, Winniford MD, Shamma AR, Sharp WJ, Blecha MB, Corson JD. A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg. 1991;13:328–33 (discussion 333–325).

    Article  CAS  Google Scholar 

  127. Toursarkissian B, Allen BT, Petrinec D, Thompson RW, Rubin BG, Reilly JM, Anderson CB, Flye MW, Sicard GA. Spontaneous closure of selected iatrogenic pseudoaneurysms and arteriovenous fistulae. J Vasc Surg. 1997;25:803–8 (discussion 808–809).

    Article  CAS  Google Scholar 

  128. Lonn L, Olmarker A, Geterud K, Risberg B. Prospective randomized study comparing ultrasound-guided thrombin injection to compression in the treatment of femoral pseudoaneurysms. J Endovasc Ther. 2004;11:570–6.

    Article  Google Scholar 

  129. Stone P, Lohan JA, Copeland SE, Jr. Hamrick RE, Tiley 3rd EH, Flaherty SK Iatrogenic pseudoaneurysms: Comparison of treatment modalities, including duplex-guided thrombin injection. West Va Med J; 2003, 99, 230–232

  130. Tanseco KV, Alsanjari O, Cockburn J, Hildick-Smith D. Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: an alternative to surgical repair. Catheter Cardiovasc Interv. 2021;97(7):E967–72.

    Article  Google Scholar 

  131. Le TD, Than VS, Nguyen MD. Percutaneous balloon-assisted ultrasound-guided direct glue embolization of deep femoral artery pseudoaneurysm rupture. Radiol Case Rep. 2020;16(3):425–9.

    Article  Google Scholar 

  132. Dvir D, Assali A, Porat E, Kornowski R. Distal left anterior descending coronary artery obstruction: a rare complication of transapical aortic valve implantation. J Invasive Cardiol. 2011;23:E281–3.

    Google Scholar 

  133. Nielsen HH, Klaaborg KE, Nissen H, Terp K, Mortensen PE, Kjeldsen BJ, Jakobsen CJ, Andersen HR, Egeblad H, Krusell LR, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: The STACCATO trial. EuroIntervention. 2012;8:383–9.

    Article  Google Scholar 

  134. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Detaint D, Brochet E, Messika-Zeitoun D, Francis F, Ibrahim H, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol. 2009;54:303–11.

    Article  Google Scholar 

  135. Schafer U, Deuschl F, Schofer N, Frerker C, Schmidt T, Kuck KH, Kreidel F, Schirmer J, Mizote I, Reichenspurner H, et al. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients. Int J Cardiol. 2017;232:247–54.

    Article  CAS  Google Scholar 

  136. Kakuta T, Fukushima S, Kawamoto N, Kainuma S, Tadokoro N, Ikuta A, Minami K, Kanzaki H, Amaki M, Okada A, Irie Y, Takagi K, Izumi C, Fujita T. Transaortic transcatheter aortic valve replacement in patients from a single institution-feasibility, safety, and midterm outcomes. Circ J. 2022. https://doi.org/10.1253/circj.CJ-21-0877.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Nagoya Heart Center, Nagoya, Aichi, Japan

    Takahiro Tokuda & Masanori Yamamoto

  2. Department of Cardiology, Toyohashi Heart Center, Toyohashi, Aichi, Japan

    Masanori Yamamoto

  3. Department of Cardiology, Gifu Heart Center, Gifu, Japan

    Masanori Yamamoto

Authors
  1. Takahiro Tokuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masanori Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

On behalf of OCEAN-SHD investigators

Corresponding authors

Correspondence to Takahiro Tokuda or Masanori Yamamoto.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tokuda, T., Yamamoto, M. & On behalf of OCEAN-SHD investigators. Vascular management during transcatheter aortic valve replacement. Cardiovasc Interv and Ther 38, 18–27 (2023). https://doi.org/10.1007/s12928-022-00900-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-022-00900-z

Keywords

Search

Navigation